Promethazine, on its own, does not contain codeine. Promethazine is an antihistamine, and codeine is an opioid. They are entirely separate drugs with different mechanisms, different effects, and different risk profiles. The confusion arises because pharmacies carry a well-known prescription cough syrup that combines the two in a single bottle, often labeled “promethazine with codeine” or by a brand name. But promethazine is also sold in tablets, suppositories, and syrups that contain no codeine at all. Whether your promethazine product includes codeine depends entirely on which formulation was prescribed or dispensed.
Promethazine Alone Is an Antihistamine
Promethazine hydrochloride has been available since 1946 and is classified as a first-generation antihistamine with strong sedative and antiemetic properties.1PubMed Central. Topical promethazine side effects: our experience and review of the literature It works by blocking histamine receptors, which makes it useful for allergic reactions, motion sickness, nausea, and as a pre-surgical sedative. Doctors have prescribed it for decades in pediatric and adult populations for its antihistaminic, antiemetic, and sedative properties.2PubMed. Should promethazine in liquid form be available without prescription? None of these uses require codeine, and in these standalone formulations, there is no opioid present whatsoever.
Promethazine-only products come in several forms: oral tablets (typically 12.5 mg or 25 mg), oral syrup, rectal suppositories, and injectable solutions. If you pick up a prescription labeled simply “promethazine” or “promethazine HCl,” you are getting the antihistamine alone. The label and the pharmacy printout will list only promethazine as the active ingredient. If codeine were included, it would be listed as a separate active ingredient on both the prescription label and the packaging.
The Combination Product and Why It Exists
The formulation that causes all the confusion is promethazine with codeine cough syrup, a prescription liquid that typically contains 6.25 mg of promethazine and 10 mg of codeine per 5 mL. This product is prescribed for cough suppression, usually when a cough is persistent enough to interfere with sleep or daily life and hasn’t responded to simpler treatments. Codeine acts on the brain’s cough center to reduce the urge to cough, while promethazine contributes antihistamine and mild sedative effects that can help with upper-airway irritation and restlessness.
The combination is not accidental. Promethazine can enhance the sedating and pain-relieving effects of opioids like codeine, which is one reason the two are sometimes paired.3PubMed Central. Promethazine use among chronic pain patients The promethazine component also helps manage nausea, a common side effect of codeine. So the pairing serves a practical clinical purpose: the antihistamine dries secretions and calms nausea while the opioid suppresses the cough reflex. But this potentiation is also what makes the combination riskier than either drug alone, particularly for respiratory depression.
Promethazine With Dextromethorphan, the Non-Opioid Alternative
Adding to the naming confusion, there is another combination syrup: promethazine with dextromethorphan (often abbreviated promethazine-DM). Dextromethorphan is a cough suppressant that is not an opioid, even though it is distantly related to opioids in its chemical structure. It does not bind to opioid receptors at normal doses and does not produce the same kind of sedation or euphoria that codeine can. This combination pairs promethazine’s antihistamine effects with dextromethorphan’s cough-suppressing action, and it has been studied as a formulation with advantages like enhanced effectiveness and fewer drawbacks compared to each ingredient alone.4Science & Technology Development Journal – Health Sciences. Preparation of cough syrup containing dextromethorphan HBr, promethazine HCl and preliminary assessment of formulation stability
If your prescription says “promethazine-DM” or lists dextromethorphan as the second active ingredient, there is no codeine in your bottle. This matters quite a bit, because promethazine-DM carries a different side-effect profile and is not a controlled substance in the same way that the codeine-containing version is. In the United States, codeine-containing cough syrups are Schedule V controlled substances (the lowest schedule, but still controlled), meaning they require a prescription and their dispensing is tracked. Promethazine-DM does not have that restriction.
How to Tell Which Formulation You Have
If you are unsure whether your promethazine product contains codeine, the simplest check is the label itself. Every prescription bottle in the U.S. lists all active ingredients and their strengths. Look for:
- Promethazine HCl only: No opioid. Used for nausea, allergies, or sedation.
- Promethazine with codeine: Contains both drugs. Prescribed for cough. The label will list codeine phosphate as a separate active ingredient, typically 10 mg per 5 mL.
- Promethazine with DM: Contains promethazine and dextromethorphan. No codeine, no opioid. Also prescribed for cough.
The pharmacy printout stapled to the bag usually spells this out in plain language, including warnings about opioid content if codeine is present. If you are still uncertain, your pharmacist can confirm in seconds. This is not a trivial distinction: the presence or absence of codeine changes the legal classification of the product, the risk of dependence, the potential for dangerous drug interactions, and whether you can safely drive or operate machinery after taking it.
Why People Respond to Codeine Differently
Even when codeine is present in a promethazine formulation, it doesn’t affect everyone the same way, and the reason is genetic. Codeine is what pharmacologists call a “prodrug.” It does very little on its own. Your liver has to convert it into morphine before it provides meaningful pain relief or cough suppression. The enzyme responsible for this conversion is called CYP2D6, and the gene that codes for it varies widely across the population.5PubMed Central. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype
Some people are “poor metabolizers,” meaning their CYP2D6 enzyme barely works. For them, codeine provides almost no cough suppression or pain relief because very little morphine is being produced. At the other extreme are “ultrarapid metabolizers,” who carry extra copies of the functional gene and convert codeine into morphine much faster and in greater amounts than normal. In these individuals, even a small dose of codeine can produce dangerously high morphine levels. One well-documented case involved a patient who developed life-threatening opioid toxicity after receiving only small doses of codeine for a cough, because genotyping revealed he had three or more functional copies of the CYP2D6 gene.6PubMed. Codeine intoxication associated with ultrarapid CYP2D6 metabolism Normal metabolizers convert roughly 5 to 15 percent of a codeine dose into morphine, but ultrarapid metabolizers can convert substantially more.7Prescriber Update. Spotlight on Codeine
This genetic variability is one reason that codeine-containing products, including promethazine-codeine syrup, have come under increasing scrutiny. Clinical guidelines now recommend considering a patient’s CYP2D6 status before prescribing codeine, and for ultrarapid metabolizers, the recommendation is to avoid codeine entirely and use an alternative analgesic or cough suppressant.5PubMed Central. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype
The Risks of Combining Promethazine With Opioids
Whether the opioid in question is codeine or something stronger, promethazine amplifies certain opioid effects in ways that can be dangerous. Promethazine potentiates opioid sedation, meaning it makes you drowsier and more impaired than you would be on either drug alone. The combination can cause respiratory depression, delirium, and profound disorientation.3PubMed Central. Promethazine use among chronic pain patients Research on chronic pain patients found that people who used promethazine alongside opioids described a “high” qualitatively different from opioid use by itself, with many reporting being severely incapacitated during the period of combined use.3PubMed Central. Promethazine use among chronic pain patients For this reason, prescribing guidelines recommend reducing the opioid dose whenever promethazine is given alongside it.
This potentiation effect is not limited to prescription scenarios. It is also the pharmacological basis for the recreational misuse of promethazine-codeine syrup, where the sedative interaction between the two drugs is specifically sought out.
The “Purple Drank” Problem
Promethazine-codeine cough syrup became one of the most culturally visible drugs of misuse in the United States over the past three decades. Beginning in the early 1990s, reports emerged of people mixing the syrup with soft drinks and sometimes alcohol, creating a concoction known by street names like “purple drank,” “lean,” or “sizzurp.”8PubMed. “Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications The purple color comes from the syrup itself, which many manufacturers dye purple or red.
The practice gained widespread attention through its association with hip-hop culture, but research shows that misuse is not confined to any single demographic. A study of young adults outside of the Houston, Texas area, where the trend was first documented, found that purple drank use occurred across racial and ethnic groups and was not limited to the population initially associated with it in media coverage.9PubMed. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures The euphoric and tranquilizing effects that users seek come from the codeine-promethazine interaction described above: the opioid provides a mild high while the antihistamine deepens the sedation and calms nausea. Adding alcohol to the mix further increases the risk of respiratory depression and overdose.
This pattern of misuse is a major reason why promethazine-codeine syrup is more tightly regulated than it once was, and why pharmacists and prescribers may be cautious about dispensing it. It is also worth noting that the misuse involves specifically the combination product. Promethazine-only syrup and promethazine-DM syrup do not carry the same misuse profile, because they lack the opioid component that drives the euphoric effect.
Pediatric Safety Concerns
Promethazine carries a boxed warning, the most serious type of safety warning the FDA issues, regarding use in children under two years of age. The warning relates to the risk of fatal respiratory depression in very young children.2PubMed. Should promethazine in liquid form be available without prescription? This applies to promethazine in all its formulations, not just the codeine-containing version. The sedative properties of promethazine alone are strong enough to suppress breathing in small children, whose airways and respiratory drive are not yet fully developed.
When codeine is also present, the pediatric risk is compounded. Children who happen to be ultrarapid CYP2D6 metabolizers face the same danger of excessive morphine production described earlier, and because of their smaller body size and developing organ systems, they have less margin for error. Several countries have restricted or banned the use of codeine in children under 12 for any indication, and some agencies extend caution through adolescence. If a child needs cough suppression, a prescriber today is far more likely to recommend a non-codeine formulation or a non-pharmacological approach than to reach for promethazine-codeine syrup.
When Promethazine Shows Up in Drug Tests
People sometimes worry that taking promethazine will cause them to fail a drug test for opioids. If your product contains only promethazine, it will not trigger a positive result for opioids, because there are no opioids in it. Promethazine is an antihistamine and does not metabolize into anything that standard immunoassay drug screens detect as an opioid. However, promethazine with codeine is a different story. Codeine and its metabolite morphine will show up on a standard urine drug test for opioids, sometimes for two to three days after the last dose depending on how much was consumed and your individual metabolism.
If you are subject to workplace drug testing or are on a monitoring program and have a legitimate prescription for promethazine-codeine syrup, keeping a copy of the prescription or having your prescriber provide documentation is the standard way to address a positive result. The medical review officer who interprets the test will typically accept a valid prescription as an explanation. But again, none of this applies to promethazine-only or promethazine-DM products.
Why the Naming Creates Real-World Confusion
Part of the ongoing confusion stems from how people talk about these products casually. A doctor might say “I’m prescribing promethazine for your cough” and mean the combination product, because in the context of cough treatment, the codeine component is implied. A pharmacist might refer to the syrup by its color or a shorthand brand name. Patients who have taken the combination product in the past may simply remember it as “promethazine” and not realize that the codeine was a separate ingredient doing most of the cough-suppressing work. This shorthand is sloppy but extremely common, and it leads people to assume promethazine inherently contains codeine when it does not.
The distinction matters in practice. If you are allergic to codeine or opioids, you can still safely take promethazine-only products for nausea or allergies. If you are in recovery from opioid addiction, promethazine alone is not an opioid and does not activate opioid receptors, though you should always disclose your history to your prescriber. And if you are prescribed promethazine for nausea and are worried about opioid side effects, you can relax: unless the label explicitly lists codeine or another opioid as an active ingredient, there is none in your medication.
Promethazine Without a Prescription
The regulatory status of promethazine varies by country. In the United States, all formulations of promethazine currently require a prescription. This was not always the case: at one point, the manufacturer sought FDA approval to sell liquid promethazine allergy and cold products over the counter.2PubMed. Should promethazine in liquid form be available without prescription? That proposal raised safety concerns, particularly around pediatric dosing and the drug’s strong sedative effects, and promethazine has remained prescription-only in the U.S. In some other countries, low-dose promethazine tablets can be purchased without a prescription for short-term use as a sleep aid or antihistamine, though the trend in several markets has been toward tightening access.
Codeine-containing products have their own separate regulatory trajectory. Many countries that once allowed low-dose codeine products over the counter have moved them behind the pharmacy counter or made them prescription-only, driven by concerns about dependence and the pharmacogenomic risks described above. Australia, for example, reclassified all codeine products to prescription-only in 2018. The regulatory stories of promethazine and codeine are intertwined where the combination product is concerned but otherwise follow independent paths, which further underscores that they are distinct medications that happen to share shelf space in one particular syrup.